Synthesis and Evaluation of 4(3H) -Quinazolinone Derivatives Bearing Aromatic Amine Side Chains As Antitumor Agents

CAO Sheng-Li,FENG Yu-Ping,ZHANG Mei,JIANG Yu-Yang,YU Xiao-Qing,MO Zhuo-Hua
DOI: https://doi.org/10.3724/j.issn.1000-0518.2007.2.162
2007-01-01
Abstract:Based on the structural feature of nonclassical antifolates, a series of 4 (3H)-quinazolinone derivatives bearing aromatic amine side chains have been designed by incorporating trimethoxyphenyl, an antitumor pharmacophore, with 4 (3H)-quinazolinone. N-alkylation of 3,4,5-trimethoxyphenylamine with appropriate amount of alkyl halides afforded 4 kinds of N-substituted 3,4,5-trimethoxyphenylamines in 30.3%~60.6% yields. The target compounds 8a 8m were obtained through the reactions of 6-bromo-2-methyl-4 (3H)-quinazolinone with 3,4,5-trimethoxyphenylamine, N-substituted 3,4,5-trimethoxyphenylamines or other arylamines at room temperature in 30.8%~71.9% yields, and their structures were confirmed by means of ESIMS, 1H NMR, elemental analysis or HRMS. The in vitro cytotoxicities against A-549 (human non-small cell lung cancer), HCT-8 (human colon cancer) and Bel-7402 (human liver cancer) cell lines of the synthesized compounds 8a~8m were tested with colorimetric MTT assay, and the results indicated that the percent growth inhibition against A-549, HCT-8 and Bel-7402 cell lines at 5×10^(-6)g/mL concentration of the compounds 8a~8m were all lower than 25%.
What problem does this paper attempt to address?